Trending - Altmetric
- Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell TherapyLast mentioned on Wed Nov 17 2021
- In This IssueLast mentioned on Thu Nov 25 2021
- Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple MyelomaLast mentioned on Thu Nov 18 2021
- Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic MalignanciesLast mentioned on Wed Nov 17 2021
- Bispecific Antibodies in Multiple Myeloma: Present and FutureLast mentioned on Thu Nov 04 2021
- Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic TargetLast mentioned on Sat Nov 13 2021
- Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19Last mentioned on Fri Nov 12 2021
- NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-ReactivityLast mentioned on Fri Nov 19 2021
- In This IssueLast mentioned on Wed Nov 24 2021
- Don't Compromise Myeloma Care Due to COVID-19 Pandemic!Last mentioned on Sat Nov 06 2021
- Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsLast mentioned on Mon Nov 15 2021
- Overcoming Acquired Epigenetic Resistance to BTK InhibitorsLast mentioned on Tue Nov 16 2021
- How to Provide the Needed Protection from COVID-19 to Patients with Hematologic MalignanciesLast mentioned on Mon Nov 22 2021
- Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1Last mentioned on Mon Nov 15 2021
- Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaLast mentioned on Mon Nov 15 2021